Delta‐slope of alpha‐fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer

Integration of the AFP delta‐slope with conventional criteria may further improve patient selection and post‐LT outcomes; prospective studies are needed to validate the present proposed model.